Purchase this article with an account.
E. Shay, H. He, S. Zhang, S. C. G. Tseng; Hyaluronan Complex Purified From Human Amniotic Membrane Extract Inhibits Proliferation of Endothelial Cells (HUVEC) and Macrophages (RAW264.7). Invest. Ophthalmol. Vis. Sci. 2009;50(13):5560.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Amniotic membrane (AM) and its extract (AME) have anti-angiogenic and anti-inflammatory actions. We speculate that hyaluronan (HA) complex such as HC-HA (the heavy chain (HC) of inter--trypsin inhibitor (II) complexed with HA) contributes to these effects and sought to purify and characterize this complex from AME.
AME was obtained from AM extracted in PBS. Subsequently, H fraction, which contains HC-HA complex, was purified from AME by two rounds of ultracentrifugation with CsCl/4M guanidine. The purity of H fraction was examined by SDS-PAGE with Coomassie blue staining. The size and quantity of HA in H fraction was determined by agarose gel electrophoresis followed by staining with Stains-All dye.HC-HA complex in H fraction was demonstrated by treatment of H fraction with hyaluronidase (HAase) or 0.05 N NaOH followed by Western blotting with anti-II antibody. The effects of H fraction on cell morphology and proliferation of HUVEC and RAW264.7 were shown by phalloidin staining, MTT assay, and BrdU labeling/staining.
H fraction contains very little protein based on Coomassie blue staining. HA in H fraction was high molecular weight (> 6000-kDa) and covalently linked with HC, which was released from HA after HAase digestion or NaOH treatment. Inclusion of H fraction in the medium significantly reduced filamentous actin, and significantly suppressed proliferation in HUVEC using MTT assay (from 0.28 ± 0.02 to 0.11 ± 0.02, p=0.0004) and in RAW264.7 cells (from 0.82 ± 0.13 to 0.43 ± 0.04, p=0.0002). BrdU labeling and staining further confirmed such suppression in HUVEC (from 0.32±0.04 to 0.02±0.03, p=0.00005) and in RAW264.7 cells (p=0.03).
HC-HA complex in H fraction was a potential factor contributing to suppressing activation and proliferation in HUVEC and macrophages. These effects explain, at least partially, AM’s activity against angiogenesis and inflammation.
This PDF is available to Subscribers Only